Jiaxi Zhu
Overview
Explore the profile of Jiaxi Zhu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
98
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang L, Kou Z, Zhu J, Zhu X, Gao L, Zhu H
Cancer Med
. 2025 Mar;
14(5):e70749.
PMID: 40062654
Background: Although Proline-rich Protein 11 (PRR11) abnormalities are closely associated with carcinogenesis, the precise mechanism of bladder cancer remains unclear. Here, we sought to elucidate the molecular mechanisms of PRR11...
2.
Zhu J, Zhu Y, Zhang W, Wang Z, Ye X, Zhou M, et al.
JTCVS Open
. 2024 Nov;
21:90-108.
PMID: 39534354
Objectives: The guidelines recommend fractional flow reserve-guided coronary artery bypass grafting (CABG) during primary valve surgery without evidence. Quantitative flow ratio (QFR) is a novel coronary angiography (CAG)-based fractional flow...
3.
Long M, Zhu J, Wang X, Hu S, Zhang J, Cheng K, et al.
Sci Total Environ
. 2024 Jul;
949:175002.
PMID: 39053529
Groundwater contamination by nitrates presents significant risks to both human health and the environment. In groundwater characterized as oligotrophic-low in organic carbon, but abundant in carbonate and phosphate-chemolithoautotrophic bacteria, including...
4.
Liu Y, Bu Q, Hu D, Chen C, Zhu J, Zhou Q, et al.
Exp Cell Res
. 2024 Jun;
440(1):114137.
PMID: 38897410
Glaucoma is characterized by pathological elevation of intraocular pressure (IOP) due to dysfunctional trabecular meshwork (TM), which is the primary cause of irreversible vision loss. There are currently no effective...
5.
Li D, Shi X, Zhu J, Cao T, Ma X, Li M, et al.
Nat Commun
. 2024 May;
15(1):4242.
PMID: 38762562
P-type FeCoSb-based skutterudite thin films are successfully fabricated, exhibiting high thermoelectric performance, stability, and flexibility at medium-to-high temperatures, based on preparing custom target materials and employing advanced pulsed laser deposition...
6.
Liu Y, Qin K, Zhu J, Yao H, Wang Z, Zhou M, et al.
J Thorac Dis
. 2024 Jan;
15(12):6408-6418.
PMID: 38249909
Background: The actual patency rate of the radial artery (RA) grafts 1 week and 1 year after coronary artery bypass grafting (CABG) has not been extensively reported on. We used...
7.
Zhu C, Zhu J, Wang L, Xiong S, Zou Y, Huang J, et al.
Sci Rep
. 2023 Mar;
13(1):5034.
PMID: 36977687
To establish a risk prediction model and make individualized assessment for the susceptible diabetic retinopathy (DR) population in type 2 diabetic mellitus (T2DM) patients. According to the retrieval strategy, inclusion...
8.
Gordon L, Karmali R, Kaplan J, Popat R, Burris 3rd H, Ferrari S, et al.
Oncotarget
. 2023 Jan;
14:57-70.
PMID: 36702329
We report an updated analysis from a phase I study of the spleen tyrosine kinase (SYK) and FMS-like tyrosine kinase 3 inhibitor mivavotinib, presenting data for the overall cohort of...
9.
Hanley M, DArcangelo M, Felip E, Garrido P, Zhu J, Ye M, et al.
J Clin Pharmacol
. 2022 Dec;
63(5):583-592.
PMID: 36579743
Brigatinib is a next-generation anaplastic lymphoma kinase (ALK) inhibitor approved for the treatment of patients with ALK-positive (ALK+) non-small cell lung cancer (NSCLC). A phase 1 drug-drug interaction study was...
10.
Yao H, Qin K, Liu Y, Yang Y, Zhu J, Chen A, et al.
Front Cardiovasc Med
. 2022 Dec;
9:1023004.
PMID: 36561777
Background: Dual antiplatelet therapy (DAPT) is recommended in patients undergoing off-pump coronary artery bypass graft surgery (OPCAB). Clopidogrel is less effective among patients with loss-of-function (LoF) of alleles, while ticagrelor...